Download presentation
Presentation is loading. Please wait.
Published byMeagan Hudson Modified over 9 years ago
1
HYPOGLYCEMIC AGENTS Rama B. Rao, M.D. Bellevue Hospital Center/NYUMC New York, N.Y.
2
Glycemic Control Agents Insulin Sulfonylureas Meglitinides: Repaglinide Biguanides: Metformin Thiazolidinediones: Pioglitazone Glucosidase inhibitors
3
Glycogen Glucose MUSCLE CELL Storage P Pyruvate Kreb’s Oxidative ATP Phosphorylation Cycle I I
4
Glucose MUSCLE CELLS P Pyruvate I Kreb’s ATP Glycogen EPINEPHRINE GLUCAGON Oxidative Phosphorylation
5
Glucose MUSCLE CELLS P Pyruvate I Kreb’s ATP KETONES FFA Phosphorylation Oxidative
6
P Glycogen Glucose BRAIN Pyruvate Krebs Oxidative Phosphorylation ATP KETONES
7
HYPOGLYCEMIA Hunger/Anxiety Focal neurological deficits Confusion Seizures Coma Hypothermia
8
P Glucos e BRAIN: Anterior Pituitary ATP GH EXCITATORY NT Adrenal medulla Catecholamines
9
Other Manifestations Tachycardia Tremor Diaphoresis
10
ALPHA CELL OF PANCREAS GLUCAGON Decreased Glucose Catecholamines, Amino acids
11
Glucose MUSCLE CELLS P Pyruvate I Kreb’s ATP Glycogen EPINEPHRINE GLUCAGON Oxidative Phosphorylation
12
Glycogen Glucose LIVER CELL Storage I P Pyruvate Kreb’s ATP EPINEPHRINE GLUCAGON Oxidative Cycle Phosphorylation
13
Ca 2+ PANCREAS: BETA ISLET CELL Insulin ++ +++++ MEMBRANE DEPOLARIZATION
14
K+K+ ATP Ca 2+ PANCREAS: BETA ISLET CELL Insulin Sulfonylurea, Meglitinides* +++++ *Repaglinide
15
SULFONYLUREAS Risk of hypoglycemia –Fasting –Elderly: variable data –Chronic renal failure
16
SULFONYLUREA INDUCED HYPOGLYEMIA Administration of glucose for acute correction Decontamination Nutrition, IV access Admission
17
SULFONYLUREAS Monitor potassium, phosphate Urinary alkalinization for chlorpropamide Octreotide for refractory hypoglycemia Observation for at least 12 hours after last dose octreotide
18
Octreotide Dosing Adults: 50 g subcutaneously every 6 hours Children: 4-5 g/kg/day subcutaneously divided every 6 hours, with maximum not exceeding the adult dose
19
K+K+ ATP Ca 2+ PANCREAS: BETA ISLET CELL Insulin DIAZOXIDE - - - - -- - -
20
Ca 2+ PANCREAS: BETA ISLET CELL Insulin OCTREOTIDE G
21
SUFONYLUREAS: Other Effects Inhibition of aldehyde dehydrogenase SIADH
22
INSULIN Oral exposure is benign Parenteral Exposures –Unpredictable in overdose –May be dependent upon quantity injection –Formulation Treatment: nutrition, supplemental glucose infusion
23
HYPOGLYCEMICS: MANAGEMENT Identify and treat hypoglycemia Admission especially if brought to coma or seizure Nutrition –Consider enteral infusion of feeds via NG Tube Monitor electrolytes
24
GLUCOSE ADMINISTRATION Adults –D 50 W 1 gram/kg Children –D 25 W 0.5-1 gram/kg –D 10 W 0.5-1 gram/kg in neonates Infusion of D 10 W at a total of 1 gram/kg/hr Monitor potassium
25
METFORMIN Rarely causes true hypoglycemia Adverse reaction –Lactic acidosis only in patients with renal insufficiency or shock states. –Treatment of lactic acidosis: hemodialysis Caveat: Co-ingested substances
26
Glycogen Glucose MUSCLE CELL P Pyruvate I Kreb’s ATP METFORMIN Oxidative Phosphorylation
27
Glycogen LIVER CELL P Pyruvate ATP METFORMIN Phosphorylation Oxidative
28
OTHER AGENTS AFFECTING CARBOHYDRATE METABOLISM Ethanol Beta adrenergic antagonists Unripened ackee fruit Valproic acid Salicylates Pentamidine Quinidine Disopyramide
29
Glycogen Glucose LIVER CELL Pyruvate Oxidative ATP Lactate Phosphorylation NAD+ NADH+H + ETHANOL Acetate
30
ALPHA CELL OF PANCREAS GLUCAGON Decreased Glucose Catecholamines, Amino acids BETA ADRENERGIC ANTAGONISTS
31
Glycogen LIVER CELL P Pyruvate ATP Phosphorylation Oxidative ACKEE
32
Glucose LIVER P Pyruvate I Kreb’s ATP KETONES FFA Phosphorylation Oxidative ACKEE VALPROIC ACID
33
Glucose LIVER P Pyruvate I Kreb’s ATP Phosphorylation Oxidative Alanine SALICYLATES
34
Ca 2+ PANCREAS: BETA ISLET CELL Insulin ++ +++ Membrane depolarization PENTAMIDINE ALLOXAN STREPTOZOCIN
35
P BRAIN Pyruvate Kreb’s Oxidative Phosphorylation ATP Acetyl Co A THIAMINE GLUCOSE
36
Glycogen Glucose MUSCLE CELL Storage P Pyruvate Kreb’s Oxidative ATP Phosphorylation Cycle I I
37
Glucose MUSCLE CELLS P Pyruvate I Kreb’s ATP Glycogen EPINEPHRINE GLUCAGON Oxidative Phosphorylation
38
Glucose MUSCLE CELLS P Pyruvate I Kreb’s ATP KETONES FFA Phosphorylation Oxidative
39
P Glycogen Glucose BRAIN Pyruvate Krebs Oxidative Phosphorylation ATP KETONES
40
Glycogen Glucose LIVER CELL Storage I P Pyruvate Kreb’s ATP EPINEPHRINE GLUCAGON Oxidative Cycle Phosphorylation
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.